Decreased bone turnover in oral contraceptive users

Bone

Volumn 16, Issue 5, 1995, Pages 499-503

  Garnero, P ^a   Sornay Rendu, E ^a   Delmas, P D ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Bone markers; Bone specific alkaline phosphatase; Oral contraception; Osteocalcin; Pyridinoline crosslinks

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT; OSTEOCALCIN;

ABSORPTIOMETRY; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY FAT; BODY HEIGHT; BODY WEIGHT; BONE MASS; BONE TURNOVER; CALCIUM INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FITNESS; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OSSIFICATION; OSTEOLYSIS; PREMENOPAUSE; SMOKING HABIT;

BIOLOGY; COHORT ANALYSIS; CONTRACEPTION; CONTRACEPTIVE METHODS; CROSS SECTIONAL ANALYSIS; DEVELOPED COUNTRIES; EUROPE; FAMILY PLANNING; FRANCE; MEDITERRANEAN COUNTRIES; ORAL CONTRACEPTIVES; ORAL CONTRACEPTIVES, COMBINED; PHYSIOLOGY; PROSPECTIVE STUDIES; RESEARCH METHODOLOGY; RESEARCH REPORT; SKELETAL EFFECTS; STUDIES; WESTERN EUROPE;

ADULT; ALKALINE PHOSPHATASE; AMINO ACID SEQUENCE; BONE AND BONES; BONE DENSITY; BONE RESORPTION; COHORT STUDIES; CONTRACEPTIVES, ORAL; CROSS-SECTIONAL STUDIES; DENSITOMETRY, X-RAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; ETHINYL ESTRADIOL; FEMALE; FEMUR; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OSTEOCALCIN; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN; PROSPECTIVE STUDIES; RADIUS;

EID: 0029120964     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/8756-3282(95)00075-O     Document Type: Article

References (39)

1. Estrogen status and heredity are major determinants of premenopausal bone mass.
2. Immunoassay for quantifying type I collagen degradation products in urine evaluated
3. Changing osteocalcin concentrations during pregnancy and lactation: Implications for maternal mineral metabolism
4. Oral contraceptive pill use and fractures in women: A prospective study
5. An immunoassay for deoxypyridinoline. A highly specific marker of bone resorption
6. Menstrual history as a determinant of current bone density in young athletes
7. Influence of oral contraceptive use on bone density in climateric women
8. Evaluation of dietary calcium content by frequential self-questionnaire
9. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease
10. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease
11. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay
12. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro
13. Bone mineral: Effects of oral contraceptives, pregnancy, and lactation
14. Osteocalcin in human serum: A circadian, rhythm
15. A specific immunoassay for monitoring human bone resorption: Quantitation of type 1 collagen cross linked N-telopeptides in urine
16. Measurements of bone collagen degradation in hyperthyroidism and during thyroxine replacement therapy using pyridinium cross links as specific urinary markers
17. Association of parity, breastfeeding, and birth control pills with lumbar spine and femoral neck densities
18. Early menopausal changes in bone mass and sex steroids
19. Oral contraceptive use may protect against low bone mass
20. Bone mineral density measured by dual-energy X-ray absorptiometry in healthy finnish women
21. The effect of oral contraceptive use on vertebral bone mass in pre- and postmenopausal women
22. Long-term oral contraceptive use does not affect trabecular bone mineral density
23. Changes in Biochemical Markers of Osteoblastic Activity during the Menstrual Cycle*
24. Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause
25. Osteoporosis in women with anorexia nervosa
26. Evaluation of urinary hydroxypyridinium cross link measurements as resorption markers in metabolic bone diseases
27. Bone density in users of combined oral contraception: Preliminary reports of a pilot study
28. Osteoporosis in anorexia nervosa: The influence of peak bone density, bone loss, oral contraceptive use, and exercise
29. Immunoassay for urinary pyridinoline. The new marker of bone resorption
30. Sex steroids and bone mass. A study of changes about the time of menopause
31. Sex steroids and bone density in premenopausal and perimenopausal women
32. Determinants of bone density in normal women: risk factors for future osteoporosis?
33. Unchanged biochemical indices of bone turnover despite fluctuations in 1,25dihydroxyvitamin D during menstrual cycle
34. The effect of previous oral contraceptive use on bone mineral density in perimenopausal women
35. Urinary excretion of pyridinium crosslinks: A new marker of bone resorption in metabolic bone diseases
36. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links
37. A serum propeptide immunoassay for the C-temunal propeptide of type I collagen